News by Tag: Pharma

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world

October 12, 2021

The Companion Diagnostics Development Services Market
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise

October 12, 2021

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis
Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models.

October 11, 2021

The nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030, predicts Roots Analysis
Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models.

October 11, 2021

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers

September 17, 2021

The biopharmaceutical CROs market is projected to be worth USD 67 billion by 2030, claims Roots Analysis
Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order to remain competitive, flexible, and profitable in the industry

September 16, 2021

The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status

September 16, 2021

The polycystic ovary syndrome market, is anticipated to be worth USD 5 billion by 2031, growing at an annualized rate of 4%, claims Roots Analysis
polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors

September 16, 2021

Manufacturing Market Continuous (Small Molecules and Biologics) by Roots Analysis
An analysis of the various partnerships related to continuous manufacturing, which have been established since 2013

September 7, 2021

Novel Vaccine Delivery Devices Market, 2019-2030 by Roots Analysis
There is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

September 6, 2021

There are over 25 technology platforms available for use in therapy development efforts.
In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market.

September 2, 2021

TIL-based Therapies Market, 2021-2030 by Roots Analysis
In addition, the clinical success in this domain is likely to draw in investments that will support ongoing and anticipated therapy development initiatives.

September 2, 2021

The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis
A detailed overview of the current market landscape of companies engaged in manufacturing prefilled syringes.

September 1, 2021

Next Generation Immune Checkpoint Inhibitors and Stimulators Market by Roots Analysis
Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential

August 30, 2021

Manufacturing Market Continuous by Roots Analysis
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step

August 30, 2021

Human Factors Engineering and Usability Testing Services Market by Roots Analysis
This has led many device developers to resort to human factors engineering and usability testing.

August 26, 2021

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030
Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs

August 13, 2021

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

July 29, 2021

The “Encapsulated Cell Therapies and Encapsulation Technologies Market” report
An in-depth analysis of the patents that have been published related to cell encapsulation technologies.

July 26, 2021

Risk factors involved in PCD Pharma Franchise
A famous quote states “If you don’t take risks you’ll never know

July 13, 2021

What are the best products to start a PCD Pharma Franchise business?
The question of selecting the right product for a pharmaceutical franchise sometimes creates confusion.

July 9, 2021

Why is the Pharma Franchise Better than Finding Marketing Jobs
After graduation in pharmacy, what do you feel? Well, you feel stuck on a level. There are many job options, and choosing the best one is difficult.

June 29, 2021

How to identify generic medicine
What are generic drugs? A generic prescription is a product created in dosage form, protection

June 25, 2021

How PCD pharma franchise is more rewarding than other businesses?
Good businesses generate missions to drive their profits. Great businesses generate profits to drive their missions”; said a quote.

June 22, 2021

Top Pharma Franchise Company in India
Penlon India Pharmaceuticals is best pharmaceutical company in India

June 22, 2021

How to Proceed In Business with Pharma Franchise Concept
How to Begin PCD Pharma Franchise Business – Pharma Franchise Business is at boom organize in all over world

June 17, 2021

SOTAX Group to Acquire Majority Stake in Ortiv-Q3
SOTAX not only strengthens its reach to a major geographic area but also gains access to new technical capabilities and resources that are built up within Ortiv.

June 15, 2021

Steps to Find a Genuine PCD Pharma Franchise
When you opt for becoming a pharma franchise owner

June 9, 2021

7 Key Rewards of Pharma Franchise Business
PCD Pharma Franchise is now one of the most profitable businesses in the existing drug market

June 8, 2021

Which Pharma Franchise Company to Choose for Franchise Marketing?
It is a frustrating situation when you look for a PCD pharma franchise company.

May 12, 2021

10th Edition of International Conference on World Pharmaceutical Sciences & Drug Delivery
The theme: “Exploring the latest research in Pharma and Biopharma” is designed for professionals at all levels and career phases of the Pharma industry, who want to improve their understanding of what will drive and shape the future of the market.

March 2, 2021

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030
The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

December 21, 2020

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis
The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis

December 21, 2020

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential

December 9, 2020

HOW TO SPOT THE BEST PCD PHARMA COMPANY?
When looking for a franchise that offers the best pharmaceutical products, one has to keep a lot of things in mind before choosing. It is easy to randomly search for a company near you but exactly how much quality product do they offer?

October 8, 2020

TOP 10 PCD PHARMA COMPANIES IN INDIA
Detailed description of renowned and successful PCD companies across India.

October 6, 2020

TEBillion Gains Increase in Pharmaceutical Industry's Interest Into Automation
TEBillion gets a growing interest from the Pharmaceutical Industry for its automation solutions

September 8, 2020

Pharma Water System, Water for Pharmaceutical use
Pharma Water System - Purified Water Generation System, Purified Water Storage System, Purified Water Distribution System by Aquatic Solutions Call Now 9324255877 or read more

August 29, 2020

The Price of Medicines to Maintain Health May Have too Great a Cost
The effective medicines that maintain health may seem priceless, but watch out.

July 28, 2020

The DNA-encoded libraries platforms and services market is projected to be reach USD 4 billion by 2030,
Using DNA to develop encoded libraries of pharmacological leads has enabled medical research community to assemble and maintain large collections of compounds in singular reaction tubes, capturing the attention of small and big pharma players

April 20, 2020

The cell therapy manufacturing market is estimated to reach close to USD 10 Billion by 2030, claims Roots Analysis
The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity.

April 15, 2020

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030
Roots Analysis has announced the addition of “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report to its list of offerings.

April 13, 2020

The prefilled syringes market is estimated to be worth over USD 2.5 billion by 2030, claims Roots Analysis
Roots Analysis has announced the addition of “Prefilled Syringes Market (5th Edition), 2020-2030” report to its list of offerings.

April 8, 2020

The DNA-encoded libraries platforms and services market is projected to be reach USD 4 billion by 2030.
Roots Analysis has announced the addition of “DNA-Encoded Libraries: Platforms and Services Market, 2020-2030” report to its list of offerings.

April 7, 2020

The autoinjectors market is projected to be worth around USD 1.5 Billion by 2030, claims Roots Analysis
Rise in prevalence of chronic diseases and the corresponding need to medicate frequently, have led to an increase in demand for safe, self-administrable dosing options. Autoinjectors are considered among the leading product classes in this category

April 6, 2020

The global smart lighting market is projected to reach USD 80.9 Billion by 2030 - Roots Analysis
Roots Analysis has announced the addition of “Smart Lighting Market, 2019-2030” report to its list of offerings.

April 3, 2020

The contract regulatory affairs-management services market for medical devices -RootsAnalysis
In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract service providers for regulatory submissions and navigating various challenging aspects of the product review and approval process

April 2, 2020

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis
Roots Analysis has announced the addition of “In Silico / Computer-Aided Drug Discovery Services Market.

April 1, 2020

The antibody contract manufacturing market is projected to reach USD 13.8 billion by 2030.
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

March 30, 2020

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
Roots Analysis has announced the addition of “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030

March 27, 2020

 137 123